New award for zonisamide capsules with exelan pharmaceuticals, INC. Period of performance is june 15, 2021 to june 14, 2022 with four 0NE-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0035
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$8,974,952.04
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Zonisamide Capsules. The contract, awarded on June 15, 2021, carries a ceiling value of $8,974,952.04 and encompasses a base performance period from June 15, 2021 through June 14, 2022, with four one-year option periods extending through June 14, 2026. The contract was issued without set-aside designation on an unrestricted, fully open competitive basis. No specific task orders or pricing schedules were provided in the available documentation; however, the contract structure follows the Department of Veterans Affairs' pharmaceutical prime vendor program model, wherein the National Acquisition Center establishes framework agreements for the supply of critical pharmaceutical products to federal healthcare systems. Performance of work is conducted at Exelan's primary facility in Boca Raton, Florida, with delivery to designated Department of Veterans Affairs locations.

Zonisamide is an anticonvulsant medication utilized in the treatment of epilepsy and other neurological conditions within the Department of Veterans Affairs healthcare system. This Indefinite Delivery Contract represents a critical component of the federal government's pharmaceutical procurement strategy, establishing a long-term supply relationship for this therapeutic agent across the Veterans Integrated Service Networks. The contract incorporates the 2027 Exelan Subcontracting Plan for Zonisamide Capsules, reflecting the contractor's commitment to small business subcontracting participation. As a firm-fixed-price, requirements-type contract vehicle classified under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), this award leverages pre-competed pricing structures to streamline pharmaceutical procurement across the Department of Veterans Affairs, the Department of Defense, the Bureau of Prisons, and the Indian Health Service.

Transactions

Action Obligated Date
Add Subcontract Plan P00014 · Incorporate 2027 exelan subcontracting plan for zonisamide capsules. $0
Exercise an Option P00013 · Exercising 4TH and last option year for zonisamide capsules. $0
Add Subcontract Plan P00012 · Add exelan pharmaceuticals INC subcontracting plan 2025-2026 $0
Add Subcontract Plan P00011 · Add exelan pharmaceuticals INC subcontracting plan 2024-2025 $0
Exercise an Option P00010 · Exercising option year 3. Period of performance is 6/15/2024 - 6/14/2025. $0
Other Administrative Action P00009 · Administrative change to update point of contact. $0
Supplemental Agreement for work within scope P00008 · Update to cost recovery fee (CRF) and submission of quarterly sales reports $0
Other Administrative Action P00007 · Change vendor POC from joann bute to brian christensen. $0
Other Administrative Action P00006 · Administrative modification to add new admin and sales POC. Joann bute, $0
Other Administrative Action P00005 · Administrative modification to add drug supply chain security act language to contract. $0
Exercise an Option P00004 · Exercising option year 2 for contract 36E79721D0035 - exelan pharmaceuticals, INC. For zonisamide capsules. $0
Add Subcontract Plan P00003 · Incorporate exelan pharmaceuticals, INC. 2023 subcontracting plan 4-1-2023 to 3-31-2024. $0
Exercise an Option P00002 · Exercise the first option for zonsimaide capsules with exelan pharmaceuticals, INC.with no price change. $0
Add Subcontract Plan P00001 · Incorporation of 2022/2023 small business subcontracting plan into contract. Plan effective 4/1/2022 - 3/31/2023. $0
Original award $0
Show all 15

Quick answers

Who was awarded contract 36E79721D0035?

36E79721D0035 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on June 15, 2021.

How much is contract 36E79721D0035 worth?

36E79721D0035's own ceiling is $8,974,952.

Who can order from contract 36E79721D0035?

36E79721D0035 is a single award indefinite delivery contract.

Was contract 36E79721D0035 competed?

The extent of competition for 36E79721D0035 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV